Based out of Wroclaw, Infermedica is a leading digital health company specialised in AI-powered solutions for preliminary diagnosis and patient triage. Right now, the company is operating on a goal to improve customers’ performance, increase healthcare accessibility, and reduce costs.
Partnership to deploy AI-powered virtual healthcare assistants!
Recently, the Polish company has tied up with the Redmond giant Microsoft to provide its technology to Microsoft Healthcare Service Bot, empowering healthcare organisations to build and deploy AI-powered virtual healthcare assistants at scale.
Talking about the partnership, Infermedica’s CEO, Piotr Orzechowski, tells Silicon Canals, “Microsoft helps hospitals and health systems in digitising parts of patients’ medical journeys. Within this partnership, Infermedica provides a major component which is our AI-powered engine to help with early triage and diagnosis. Our system learns over time and improves results for patients, saving costs, and resources for both payers and providers. Infermedica’s medical team has spent over thirty thousand hours verifying results and content that the system relies on. Today’s partnership brings us closer to a future where doctors have the needed assistance of high-quality AI-powered solutions, making it easier for patients to get the right care.”
Reduces stress in public and private health system!
Notably, Microsoft Healthcare Bot is used by leading health organisations, including Aurora Health Care, Premera Blue Cross, and Quest Diagnostics. By conducting automated triage powered by Infermedica’s technology, the tool helps to reduce the stress in both public and private health systems, currently overloaded by COVID-19 cases.
Also commenting on the new developments, Adam Walker, Program Manager at Microsoft Healthcare, says, “Infermedica is revolutionising the triage space, with a solution that breaks the mould. We were impressed with the sophisticated probabilistic modelling used to achieve a level of accuracy that isn’t possible with the simplistic decision tree models that we saw in the rest of the market. We chose to work with Infermedica because they bring a truly intelligent layer of clinically validated health technology to the Microsoft Healthcare Bot Service, empowering our customers to build smarter virtual assistants that drive better outcomes for patients”
Broadening access to healthcare!
Founded by Irving Loh, Piotr Orzechowski, Roberto Sicconi in 2012, Infermedica offers a range of AI products for triage and preliminary medical diagnosis, broadening the access to healthcare at an early stage.
Piotr Orzechowski, says:“Our tools help health organizations to improve medical triage and save precious resources for those who need it most.”
AI and machine learning at work!
The company uses artificial intelligence and machine learning to assess symptoms and find patterns in data. Their core products include Symptom Checker, Call Center Triage, and Infermedica API – all built around early triage and diagnosis. To date, the digital health company has helped nearly 6 million people assess their symptoms.
Infermedica’s technology is used by industry leaders including Allianz, Global Excel, and Unipol, and has performed over 5 million health checks globally.
Discussing further about the business plans Piotr Orzechowski reveals, “Our business gained a lot of traction over the last year, and especially within the last two quarters. We’ve seen an increased interest in AI-powered products and this had a big impact on the roadmap and accelerated many internal processes.”
“Being a team of almost 90 people Infermedica is working on a set of solutions that answer new needs arising from the pandemic, the business development team is busy with numerous leads gathered over the last few weeks and our medical team is working tirelessly to verify the overwhelming amount of data we’ve received. Within the next year, we plan to further increase our presence in the US and European markets and the continued development of our core products for health systems, payers, and providers. This includes several partnerships we’re currently working on closing, including one with a globally recognized insurance company from Fortune 500 list,” adds, Piotr Orzechowski.
To date, the company has raised over €3.8 million in funding. Right now, the company’s technology is offered as a white-label solution to health insurance companies, health systems, and hospitals.
Main image credits: Infermedica
Stay tuned to Silicon Canals for more European technology news